ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,988,369 | -12.7% | 1,031,259 | -1.1% | 0.01% | -9.1% |
| Q2 2023 | $32,044,974 | +88263.4% | 1,042,452 | +3.6% | 0.01% | -15.4% |
| Q1 2023 | $36,265 | -9.7% | 1,006,533 | -1.0% | 0.01% | -18.8% |
| Q4 2022 | $40,182 | -99.9% | 1,016,755 | +2.7% | 0.02% | 0.0% |
| Q3 2022 | $39,784,000 | -3.5% | 990,138 | +1.0% | 0.02% | 0.0% |
| Q2 2022 | $41,222,000 | +15.3% | 980,548 | +6.9% | 0.02% | +33.3% |
| Q1 2022 | $35,743,000 | -1.5% | 917,431 | +0.7% | 0.01% | +9.1% |
| Q4 2021 | $36,302,000 | +1.7% | 910,952 | -7.8% | 0.01% | 0.0% |
| Q3 2021 | $35,689,000 | -27.1% | 987,535 | -17.4% | 0.01% | -26.7% |
| Q2 2021 | $48,978,000 | -6.3% | 1,194,882 | -0.3% | 0.02% | -11.8% |
| Q1 2021 | $52,282,000 | +157.7% | 1,198,587 | +195.7% | 0.02% | +142.9% |
| Q4 2020 | $20,289,000 | +84.1% | 405,378 | +54.7% | 0.01% | +75.0% |
| Q3 2020 | $11,023,000 | – | 261,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |